Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLOS Global Public Health |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10766173/?tool=EBI |
_version_ | 1797362325566521344 |
---|---|
author | McNeil Ngongondo Justin Ritz Michael D. Hughes Mitch Matoga Mina C. Hosseinipour |
author_facet | McNeil Ngongondo Justin Ritz Michael D. Hughes Mitch Matoga Mina C. Hosseinipour |
author_sort | McNeil Ngongondo |
collection | DOAJ |
first_indexed | 2024-03-08T16:05:29Z |
format | Article |
id | doaj.art-637f50579432418dbb97f893bfcb4266 |
institution | Directory Open Access Journal |
issn | 2767-3375 |
language | English |
last_indexed | 2024-03-08T16:05:29Z |
publishDate | 2024-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLOS Global Public Health |
spelling | doaj.art-637f50579432418dbb97f893bfcb42662024-01-08T05:55:51ZengPublic Library of Science (PLoS)PLOS Global Public Health2767-33752024-01-0141Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trialsMcNeil NgongondoJustin RitzMichael D. HughesMitch MatogaMina C. Hosseinipourhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10766173/?tool=EBI |
spellingShingle | McNeil Ngongondo Justin Ritz Michael D. Hughes Mitch Matoga Mina C. Hosseinipour Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials PLOS Global Public Health |
title | Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials |
title_full | Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials |
title_fullStr | Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials |
title_full_unstemmed | Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials |
title_short | Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials |
title_sort | discontinuation of tenofovir disoproxil fumarate from initial art regimens because of renal adverse events an analysis of data from four multi country clinical trials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10766173/?tool=EBI |
work_keys_str_mv | AT mcneilngongondo discontinuationoftenofovirdisoproxilfumaratefrominitialartregimensbecauseofrenaladverseeventsananalysisofdatafromfourmulticountryclinicaltrials AT justinritz discontinuationoftenofovirdisoproxilfumaratefrominitialartregimensbecauseofrenaladverseeventsananalysisofdatafromfourmulticountryclinicaltrials AT michaeldhughes discontinuationoftenofovirdisoproxilfumaratefrominitialartregimensbecauseofrenaladverseeventsananalysisofdatafromfourmulticountryclinicaltrials AT mitchmatoga discontinuationoftenofovirdisoproxilfumaratefrominitialartregimensbecauseofrenaladverseeventsananalysisofdatafromfourmulticountryclinicaltrials AT minachosseinipour discontinuationoftenofovirdisoproxilfumaratefrominitialartregimensbecauseofrenaladverseeventsananalysisofdatafromfourmulticountryclinicaltrials |